Tag: physicians

Revisions to New Jersey Prescriber Gift Ban Law Proposed – Comments Due October 5th

Revisions to the Limitations on and Obligations Associated with Prescriber Acceptance of Compensation from Pharmaceutical Manufacturers law, N.J.A.C. 13:45J-1.1 et seq. (NJ Gift Ban Law), have been proposed by the New Jersey Attorney General. The NJ Gift Ban Law, originally adopted effective January 16, 2018 and previously discussed on this blog, drew […]

OIG Releases Report Re: Open Payments Program

The Health and Human Services Office of Inspector General (OIG) recently released a report on its review of the Open Payments program, titled “OPEN PAYMENTS DATA: REVIEW OF  ACCURACY, PRECISION, AND CONSISTENCY IN REPORTING.” The OIG reviewed data from calendar year 2015 available as of June 2016. The OIG’s key takeaway […]

CMS Releases New Resources, Schedules Teleconference for Sunshine Review and Dispute Process

As we informed you last week, the Open Payments review, dispute and correction process started today and will continue through September 11, 2014.  This is the process that allows physicians and teaching hospitals to review and dispute information regarding payments and other transfers of value that pharmaceutical, biotechnology and medical device manufacturers and group purchasing […]

CMS Announces Dates for Sunshine Payment Review, Dispute & Correction Process

The Centers for Medicare & Medicaid Services (CMS) announced today that the Open Payments review, dispute and correction process will begin on Monday, July 14, 2014 and continue through September 11, 2014.  Under the Sunshine Act final rule, physicians and teaching hospitals have the ability to review and dispute payments and […]

CMS RELEASES OPEN PAYMENTS REGISTRATION INFORMATION FOR PHYSICIANS AND TEACHING HOSPITALS; PHASE 2 TIMELINE FOR MANUFACTURERS AND GPOS

The Centers for Medicare & Medicaid Services (CMS) released today information regarding registration in the Open Payments system for physicians and teaching hospitals interested in reviewing and verifying data reported by pharmaceutical, biotechnology and medical device manufacturers and group purchasing organizations (GPOs) in connection with the Physician Payments Sunshine Law prior […]

Sunshine Act Brochures Provide Highlights for Patients and Physicians

The National Physician Payment Transparency Program, also known as Open Payments, affects many health care industry participants.  Accordingly, even though applicable manufacturers and applicable group purchasing organizations (GPOs) are the only entities required to report data under the program, the Centers for Medicare & Medicaid Services (CMS) is not overlooking patients […]